
How DBS Turns Insight Into Impact For Wealth Clients
In the early days of AI investing, DBS Chief Investment Officer (CIO) Hou Wey Fook made a call that raised eyebrows; he bought Nvidia when it was recognized mainly for its graphics chips.
Hou Wey Fook, DBS Chief Investment Officer
'We launched our Barbell Strategy back in 2019 and bought Nvidia when no one was really talking about it. Our rationale was based on its global leadership in GPU technology, which—though it accounted for only 50% of revenue at the time—positioned Nvidia to benefit significantly from the subsequent explosive growth of the online gaming industry.
'Since then, its share price has risen more than 30-fold. While we've had to rebalance over the years to mitigate single stock risk, we've liked it for a long, long time,' Hou says.
It wasn't a fluke. That single decision reflected the long-term, high-conviction and, at times, contrarian approach that the DBS CIO team brings to managing client portfolios.
Hou, who has spent nearly four decades across sovereign wealth, asset management and private banking, doesn't subscribe to industry silos. Rather, his team manages portfolios holistically, looking beyond asset class labels to focus on total return and resilience.
That thinking led to the creation of the DBS Barbell Strategy, which pairs high-growth equities with income-generating assets and alternative investments. 'Most of the industry is still structured in silos based on respective asset classes, but clients don't think in those terms. They want absolute return results,' he says.
The DBS Barbell Strategy has consistently outperformed its peers since its inception. By the end of 2024, the performance of the strategy (with returns of ~14%) ranked 6th out of 172 peers, placing it in the top 5% of its category.
That track record reflects the disciplined approach taken by Hou and his team. Rather than chasing market fads, they focus on companies that demonstrate consistent, long-term growth, strong competitive advantages and reliable revenue streams. Their equity picks include large-cap names like Apple, Meta and Nvidia, alongside more specialized holdings such as Netflix, chosen for its ownership of valuable content and intellectual property—factors that contribute to pricing power and resilience.
This disciplined approach extends to the income side of the barbell portfolio. The team maintains a clear focus on investment-grade bonds, prioritizing stability and capital preservation over higher-yield but higher-risk options. The goal is to deliver steady performance without unnecessary complexity or exposure.
'That side of the portfolio is about stability. We don't need to be sexy,' Hou says. This clarity of purpose also explains why DBS has been bullish on gold since the beginning of 2024—the bullion went on to hit an all-time high last October and continues to outperform today. The CIO also pushed into short-duration investment-grade credit when others bought long-term bonds instead, which saw capital losses as rates rose.
The other key element of the CIO's approach is staying ahead of structural shifts. Hou identifies three core pillars that guide its allocations: income generators, secular growth equities and alpha-generating alternative investments. His calls on tech, ASEAN resilience and even space tourism have proven timely. "We go all in when we have conviction. With AI, we saw its impact years ago and even created deepfake videos at our events to help our clients visualize the power of the technology," he says.
The same thinking led DBS to significantly expand its offerings in private assets for its private banking clients, which now includes private equity, credit, real estate and infrastructure. Its newest private market fund, launched in April, focuses on sports, media and entertainment.
For Hou, this space exemplifies many of the qualities he looks for: scarcity, content ownership and recurring income. 'Sports is a great example. There are only so many football clubs or NBA teams. With streaming, these franchises now generate steady revenues through advertising and subscriptions,' he says.
He believes private assets have an important role to play in client portfolios. Private equity, for instance, is a valuable addition to client portfolios because of its hands-on approach. Unlike passive investors, private equity managers actively work to restructure the businesses they acquire, improve operational efficiency and scale them for global growth. These firms identify companies with untapped potential and help transform them into stronger, more competitive players. As a result, the returns from private assets are derived from 'alpha,' which refers to non-market directional returns.
'With current market turbulence, these provide a strong hedge across market cycles via non-correlating returns and illiquidity premiums,' Hou added.
Eligible clients can also gain access to exclusive funds and high-growth companies in areas such as AI, biotechnology, space and other frontier technologies through the bank's private assets client club. DBS has also facilitated profitable exits in selected deals, delivering realized returns to investors.
As a global private bank with a digital exchange, DBS provides a full suite of digital asset solutions to meet unique investment needs for private banking clients, all within a trusted and regulated ecosystem. Those seeking direct exposure to cryptocurrencies can trade via DBS Digital Exchange (DDEx), while others seeking to hedge their positions against market volatility and potentially earn yield can do so through various options structures or via structured notes.
More importantly, clients can manage their cryptocurrency portfolios alongside other traditional securities within their banking dashboard, enabling them to manage their entire portfolio holistically and seamlessly.
To help clients navigate these opportunities more systematically, the DBS CIO team recently launched a new asset allocation framework inspired by the U.S. endowment model. The framework employs a 60/40 mix of traditional and alternative assets, which include hedge funds and alternative investments. Unlike others, DBS took a more rigorous approach by using advanced statistical modeling and a proprietary data science framework to determine the optimal allocation to the various asset strategies.
'No one else has done this. We wanted it to be scientific, not based on surveys or marketing,' Hou says. His team is now working on new solutions for clients to have a holistic expression for these alternatives under its new asset allocation framework.
Still, it all comes back to conviction and clarity. In volatile markets, the ability to hold your course is what separates short-term noise from long-term value. 'Everyone can copy what Warren Buffett does. But how many people can actually adhere to and abide by the strategy? The key is discipline,' Hou says.
That discipline has shaped DBS' CIO office into a market leader that avoids fads and focuses on repeatable success. As global markets continue to shift, Hou believes the most important quality investors need isn't foresight, it's patience and consistency. "There's always opportunity. But you must stay committed, stay invested and stay focused,' he says.
While global giants from Europe and the U.S. used to dominate private banking, DBS has carved out a differentiated position by being nimbler, client-centric and willing to challenge convention. Its ability to move quickly on high-conviction calls, build transparent proprietary solutions and offer institutional-grade access to private markets has resonated with Asia's growing pool of sophisticated family offices and ultra-high net worth individuals. And as more clients look for trusted guidance through a volatile landscape, that difference is starting to matter more than ever.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Wire
28 minutes ago
- Business Wire
Vantage Corp Further Expands Asia-Pacific Presence with Two Additional LOIs to Acquire a Hong Kong and Mainland China-Based Shipbroking Firm
SINGAPORE--(BUSINESS WIRE)-- Vantage Corp (NYSE American: VNTG) ('Vantage' or the 'Company'), a shipbroking company providing comprehensive services including brokerage, consultancy, and operational support in the tanker market, announced that its wholly-owned subsidiary, Vantage (BVI) Corporation, has signed two additional non-binding Letters of Intent (LOI) to acquire a Hong Kong and Mainland China-based firm specializing in shipbroking and maritime services. Following the recently announced planned acquisition of a Singapore-based shipbroking company, these two new LOIs represent the Company's first formal step toward establishing an operational hub in the Greater China region. This move reflects Vantage Corp's strategic vision to create a tri-hub model across three key maritime centers in Southeast Asia (namely Singapore, Hong Kong, and Mainland China), firmly positioning it at the core of the region's most vital shipping and trade corridors. These latest LOIs align with the Company's broader growth strategy, which focuses on acquiring established shipbroking firms to expand into new geographic markets while simultaneously strengthening its operational capabilities and service offerings. 'These planned strategic acquisitions mark a significant milestone in our long-term strategy as we expand into key maritime markets in Southeast Asia,' said Vantage Corp CEO Andresian D'Rozario. 'Establishing a presence in the Greater China region is a critical step toward realizing our vision of a tri-hub operational model across Asia, anchored in Singapore, Hong Kong, and Mainland China. This move not only strengthens our geographic footprint but also positions us to better serve our global client base across key trade routes. By integrating our expanding Asia operations with our growing and scaling presence in the Middle East, we are creating a unified and scalable business that enhances operational efficiency, deepens market penetration, and enables us to capture synergies across regions. Looking ahead, M&A will continue to remain central to our strategy, with plans to enter the United States and European market.' Each LOI outlines a framework for the potential acquisition of the respective companies, subject to the completion of customary due diligence, regulatory approvals, and the execution of definitive agreements. In line with Vantage (BVI) Corporation's confidentiality obligations, further details will be disclosed upon finalization of definitive agreements. About Vantage Corp Founded in 2012 by five seasoned shipbrokers, Vantage Corp provides comprehensive shipbroking services, including operational support and consultancy services, in the tanker markets, covering clean petroleum products ('CPP') and petrochemicals, dirty petroleum products ('DPP'), biofuels and vegetable oils. Vantage Corp also has a sales & projects team, a research/strategy team and an IT team. Vantage over the years has emerged as a trusted intermediary and a pivotal ink between oil companies, traders, shipowners, and commercial managers, ensuring smooth logistical flow for cargo deliveries to timely demurrage and claims settlements. Through its 100%-owned subsidiary Vantage (BVI) Corporation, Vantage Corp operates a growing network of regional subsidiaries, including Vantage Shipbrokers Pte Ltd (Singapore) and Vantage Nexus Commercial Brokers Co., L.L.C (UAE). Vantage Corp listed on the NYSE American on June 12, 2025. For more information, visit Forward-Looking Statements This press release contains 'forward-looking statements' within the meaning of the 'safe harbor' provisions of the Private Securities Litigation Reform Act of 1995, including statements regarding the intended use of the proceeds. You can identify forward-looking statements by the fact that they do not relate strictly to historical or current facts. These statements may include words such as 'anticipate', 'estimate', 'expect', 'project', 'plan', 'intend', 'believe', 'may', 'will', 'should', 'can have', 'likely' and other words and terms of similar meaning. Forward-looking statements represent Vantage's current expectations regarding future events and are subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those implied by the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the uncertainties related to market conditions and other factors discussed in the 'Risk Factors' section of the registration statement filed with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company's filings with the SEC, which are available for review at The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof.
Yahoo
an hour ago
- Yahoo
Celularity Completes Major Balance Sheet Restructuring, Retires All $41.6 Million in Senior Secured Debt
Retired all principal and accrued interest owed its two senior secured lenders, Resorts World Inc. Pte. Ltd., or RWI, and C.V. Starr and Co., Inc., eliminating all senior secured debt from its balance sheet. Entered into an Asset Purchase Agreement with Celeniv Pte. Ltd., or Celeniv, to monetize Celularity intellectual property assets and eliminate senior secured debt. In connection therewith entered into a License Agreement with Celeniv to license back the intellectual property assets on an exclusive basis with an exclusive five-year repurchase option. Completed an internal restructuring and realignment to create wholly owned operating subsidiaries for its four commercial businesses—advanced biomaterial products, longevity-focused cell therapy, biobanking, and contract development and manufacturing. FLORHAM PARK, N.J., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) ('Celularity'), a regenerative and cellular medicine company focused on addressing age-related and degenerative diseases, announced today that it has completed a major balance sheet restructuring resulting in the retirement of all $32.0 million of the Company's senior secured debt plus $9.6 million in associated unpaid interest. As part of this restructuring, Celularity entered into an Asset Purchase Agreement and a License Agreement with Celeniv Pte. Ltd. ('Celeniv'), a Singapore company formed by Resorts World Inc. Pte. Ltd., or RWI, one of Celularity's two senior secured lenders, and Tan Sri Dato Lim Kok Thay ('Mr. Lim'), executive chairman/non-independent executive director of Genting Group and former Celularity director. Under the Asset Purchase Agreement, Celularity sold its intellectual property assets to Celeniv, which under the License Agreement licensed those assets to Celularity on an exclusive basis for an initial term of five (5) years renewable for additional five-year terms. Celularity is required to make quarterly license payments to Celeniv under the License Agreement based on the value of the assets sold under the Asset Purchase Agreement. Celularity also has an exclusive five-year option under the Asset Purchase Agreement to repurchase the assets from Celeniv. Celularity received consideration under the Asset Purchase Agreement in the amount of $33,812,230, which it used to retire the $27,000,000 senior secured loan outstanding from RWI and the $6,812,230 Promissory Note outstanding from Mr. Lim (which Mr. Lim previously assigned to Celeniv). Previously, Celularity used part of the proceeds it received under the Promissory Note to retire the senior secured loan outstanding from C.V. Starr and Co., Inc., or Starr. Celularity was advised in the transactions by Faithstone Capital Partners. 'Under the Celeniv agreements announced today, we successfully monetized Celularity's intellectual property assets to retire the Company's senior secured debt in its entirety while retaining exclusive use of the assets for our cell therapy, advanced biomaterials, and biobanking businesses. An exclusive five-year right to repurchase those assets from Celeniv gives us additional optionality going forward,' said Robert J. Hariri, M.D., Ph.D., Celularity's Chairman and CEO. 'We believe this agreement results in a major improvement of Celularity's balance sheet with the removal of all the Company's senior secured debt, which was due for repayment in February 2026, as well as the senior secured lenders' general security interest in all Company assets. We accomplished this while preserving our exclusive use of intellectual property that is operationally aligned with our programs and commercial activities and expect to gain greater financial flexibility and potential access to lower cost traditional financing sources. We are deeply grateful to both RWI and Mr. Lim for their continued support of Celularity's mission as we embark on this new chapter.' Celularity also completed an internal restructuring including establishing operating subsidiaries for each of its functional business units, as follows: Celularity Biomaterials LLC, its advanced biomaterial products commercial unit. Celularity Longevity LLC, its cellular therapeutics products commercial unit. Celularity Advanced Manufacturing LLC, its contract development and manufacturing, or CDMO, commercial unit. Celularity Biorepository LLC, its neonatal (Lifebank) and adult cell and tissue banking commercial unit. Celularity Discovery & Development, LLC, its internal discovery and development unit. Celularity Asset Holding LLC, its internal services unit. 'This internal restructuring formalizes how we manage Celularity to optimize efficiency and financial performance across the Company's commercial units—advanced biomaterial products, longevity-focused cellular therapeutics, biobanking services, and contract manufacturing and development services—as well as our internal discovery and development unit that supports the four commercial units with new product discovery, development, and technology transfer services, and our internal business services unit. We wanted better visibility around the fact that Celularity operates four commercial businesses under one roof, in contrast to the more typical biotechnology enterprise's single-shot discovery or development stage programs,' said Dr. Hariri. About Celularity Celularity Inc. (Nasdaq: CELU) is a regenerative and aging-related cellular medicine company developing, manufacturing, and commercializing advanced biomaterial products and allogeneic and autologous cell therapies, all derived from the postpartum placenta. Celularity believes that by harnessing the placenta's unique biology and ready availability, it can develop therapeutic solutions that address significant unmet global needs for effective, accessible, and affordable therapies that target fundamental aging mechanisms like cellular senescence, age-related chronic inflammation, and tissue degeneration. For more information about Celularity and its cutting-edge regenerative medicine solutions, please visit Forward Looking Statements Certain statements in this press release are 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, without limitation, statements regarding: (i) our future sales or sales growth; (ii) our expectations for future financial results, including levels of net sales; (iii) our expectations regarding new products including our 510K products; and (iv) future demand for our products. All statements other than statements of historical facts are 'forward-looking statements,' including those relating to future events. In some cases, you can identify forward-looking statements by terminology such as 'anticipate,' 'believe,' 'can,' 'could,' 'continue,' 'expect,' 'improving,' 'may,' 'observed,' 'potential,' 'promise,' 'should,' and similar expressions (as well as other words or expressions referencing future events, conditions or circumstances). Forward-looking statements are based on Celularity's current expectations and assumptions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks, and changes in circumstances that may differ materially from those contemplated by the forward-looking statements, which are neither statements of historical fact nor guarantees or assurances of future performance. Many factors could cause actual results to differ materially from those described in these forward-looking statements, including those risk factors set forth under the caption 'Risk Factors' in Celularity's annual report on Form 10-K and Form 10-K/A for the year ended December 31, 2024 filed with the Securities and Exchange Commission (SEC) on May 8, 2025 and May 21, 2025, respectively, and other filings with the SEC. If any of these risks materialize or underlying assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that Celularity does not presently know, or that Celularity currently believes are immaterial, that could also cause actual results to differ from those contained in the forward-looking statements. In addition, these forward-looking statements reflect Celularity's current expectations, plans, or forecasts of future events and views as of the date of this communication. Subsequent events and developments could cause assessments to change. Accordingly, forward-looking statements should not be relied upon as representing Celularity's views as of any subsequent date, and Celularity undertakes no obligation to update forward-looking statements contained herein, whether because of any new information, future events, changed circumstances or otherwise, except as otherwise required by law. Carlos RamirezSenior Vice President, Celularity
Yahoo
an hour ago
- Yahoo
SlateStone Wealth names new chief equity strategist
US-based investment advisory firm SlateStone Wealth has appointed Erin Gibbs as its new chief equity strategist. Gibbs will focus on the development of a quantitative equity platform, starting with a strategy for small- and mid-cap investments and refining the execution of portfolios, the company said. She will collaborate with Daniel Payne, SlateStone's chief investment officer(CIO), to streamline the firm's fundamental and quantitative strategies. As a member of the Investment Policy Committee, Gibbs will also contribute to the alignment of portfolio strategies with the diverse needs and long-term goals of SlateStone's clientele. Erin Gibbs is an expert in quantitative equity research and portfolio strategy, with over 25 years of experience in handling institutional-level portfolios for private clients as well as international investment companies. Prior to joining SlateStone Wealth, Gibbs held the position of CIO at Main Street Asset Management and was the Equity CIO at S&P Investment Advisory Services. Her professional journey also includes senior roles at notable financial institutions such as Liberty Ridge Capital, Citigroup, and Sanford Bernstein. SlateStone Wealth, operating from Jupiter, Florida, offers a range of wealth management services to high- and ultra-high-net-worth individuals, families, family offices, and foundations across the nation. "SlateStone Wealth names new chief equity strategist " was originally created and published by Private Banker International, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data